MMP9 and renal cell carcinoma: At the same time, through in vitro experiments, it was found that its active components OA, TET and QUE can down-regulate the genes TGFB1, CCND1, ERBB2, and MMP9 that are highly expressed in RCC, and upregulate the genes CAT and PPARα that are poorly expressed in RCC.